Intensive insulin therapy: a personal and historical perspective.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Intensive therapy of Type I diabetes is a system of therapy in which the patient is the key partner in day-to-day management. A number of technical developments in the late 1970s led to the development of intensive therapy. Self-monitoring of blood glucose (SMBG) proved to be the major change agent that stimulated the revolution in diabetes management that is intensive therapy. One important event that stimulated widespread use of SMBG was the development of spring-loaded finger-pricking devices. The introduction of glycated hemoglobin measurements as an indicator of glycemic control over several weeks allowed quantitative assessment of glycemic control. The advent of continuous subcutaneous insulin infusion (CSII) stimulated thinking about insulin regimens. These advances have combined not only to facilitate development of intensive therapy as a strategy of diabetes management, but also to permit development of research protocols to assess the impact of such therapy on the chronic complications of diabetes.

Original languageEnglish
Pages (from-to)33-39
Number of pages7
JournalThe Diabetes Educator
Volume15
Issue number1
StatePublished - Jan 1 1989

Fingerprint

Insulin
Blood Glucose Self-Monitoring
Therapeutics
Subcutaneous Infusions
Glycosylated Hemoglobin A
Diabetes Complications
Type 1 Diabetes Mellitus
Fingers
Equipment and Supplies
Research

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Intensive insulin therapy : a personal and historical perspective. / Skyler, Jay S.

In: The Diabetes Educator, Vol. 15, No. 1, 01.01.1989, p. 33-39.

Research output: Contribution to journalArticle

@article{1e25177ffcb84dfa929f13626c6186a4,
title = "Intensive insulin therapy: a personal and historical perspective.",
abstract = "Intensive therapy of Type I diabetes is a system of therapy in which the patient is the key partner in day-to-day management. A number of technical developments in the late 1970s led to the development of intensive therapy. Self-monitoring of blood glucose (SMBG) proved to be the major change agent that stimulated the revolution in diabetes management that is intensive therapy. One important event that stimulated widespread use of SMBG was the development of spring-loaded finger-pricking devices. The introduction of glycated hemoglobin measurements as an indicator of glycemic control over several weeks allowed quantitative assessment of glycemic control. The advent of continuous subcutaneous insulin infusion (CSII) stimulated thinking about insulin regimens. These advances have combined not only to facilitate development of intensive therapy as a strategy of diabetes management, but also to permit development of research protocols to assess the impact of such therapy on the chronic complications of diabetes.",
author = "Skyler, {Jay S}",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "15",
pages = "33--39",
journal = "Diabetes Educator",
issn = "0145-7217",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Intensive insulin therapy

T2 - a personal and historical perspective.

AU - Skyler, Jay S

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Intensive therapy of Type I diabetes is a system of therapy in which the patient is the key partner in day-to-day management. A number of technical developments in the late 1970s led to the development of intensive therapy. Self-monitoring of blood glucose (SMBG) proved to be the major change agent that stimulated the revolution in diabetes management that is intensive therapy. One important event that stimulated widespread use of SMBG was the development of spring-loaded finger-pricking devices. The introduction of glycated hemoglobin measurements as an indicator of glycemic control over several weeks allowed quantitative assessment of glycemic control. The advent of continuous subcutaneous insulin infusion (CSII) stimulated thinking about insulin regimens. These advances have combined not only to facilitate development of intensive therapy as a strategy of diabetes management, but also to permit development of research protocols to assess the impact of such therapy on the chronic complications of diabetes.

AB - Intensive therapy of Type I diabetes is a system of therapy in which the patient is the key partner in day-to-day management. A number of technical developments in the late 1970s led to the development of intensive therapy. Self-monitoring of blood glucose (SMBG) proved to be the major change agent that stimulated the revolution in diabetes management that is intensive therapy. One important event that stimulated widespread use of SMBG was the development of spring-loaded finger-pricking devices. The introduction of glycated hemoglobin measurements as an indicator of glycemic control over several weeks allowed quantitative assessment of glycemic control. The advent of continuous subcutaneous insulin infusion (CSII) stimulated thinking about insulin regimens. These advances have combined not only to facilitate development of intensive therapy as a strategy of diabetes management, but also to permit development of research protocols to assess the impact of such therapy on the chronic complications of diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0024530125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024530125&partnerID=8YFLogxK

M3 - Article

C2 - 2642797

AN - SCOPUS:0024530125

VL - 15

SP - 33

EP - 39

JO - Diabetes Educator

JF - Diabetes Educator

SN - 0145-7217

IS - 1

ER -